Corynebacterium Probiotic to Prevent or Treat Cutaneous Staphylococcal Disease
Invention type: Technology
/
Case number: #23721J
Methods and compositions for treating a cutaneous wound to treat or limit development of a pathogenic bacterial infection are provided, involving administering to a subject having a cutaneous wound an amount effective of Corynebacteria spp., or a disclosed, composition, to treat or limit development of pathogenic bacterial infection of the wound.
Researchers
Tami Lieberman
/
Alexandra Poret
/
Victor Neel
Departments: Department of Civil and Environmental Engineering, Harvard Cross-Enrollment Prog
Technology Areas: Chemicals & Materials: Catalysis & Synthesis / Therapeutics: Proteins & Antibodies, Regenerative Medicine
Impact Areas: Healthy Living
-
corynebacterium to treat or limit cutaneous wound infection
United States of America | Published application -
corynebacterium to treat or limit cutaneous wound infection
Patent Cooperation Treaty | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.